×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Capricor Therapeutics Updates on Duchenne Treatment Progress - TipRanks.com
Tipranks
Capricor Therapeutics (CAPR) has provided an update. The Company has recently shared a presentation on the progress of its CAP-1002...
3 hours ago
Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular ...
Yahoo Finance
Company Aligned with FDA on Demonstration of Non-Clinical Comparability; Allowing for Immediate Use of San Diego Manufacturing Facility-...
5 days ago
Capricor aligns with FDA on drug pathway for muscular dystrophy
Investing.com
SAN DIEGO - Capricor Therapeutics (NASDAQ: NASDAQ:CAPR), a biotechnology firm, has reached a significant milestone in the development of its...
5 days ago
Benign Growth For Capricor Therapeutics, Inc. (NASDAQ:CAPR) Underpins Stock's 26% Plummet
Simply Wall Street
The Capricor Therapeutics, Inc. ( NASDAQ:CAPR ) share price has softened a substantial 26% over the previous 30 days...
1 week ago
Here's Why We're Not Too Worried About Capricor Therapeutics' (NASDAQ:CAPR) Cash Burn Situation
Yahoo Finance
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
5 days ago
Capricor Therapeutics to Present at Upcoming Investor Conferences
Yahoo Finance
SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell...
1 month ago
Capricor Therapeutics (CAPR) Reports Q2 Loss, Misses Revenue Estimates
Yahoo Movies UK
Capricor (CAPR) delivered earnings and revenue surprises of -7.69% and -1.46%, respectively, for the quarter ended June 2018.
2 days ago
Capricor Therapeutics Inc (CAPR) Reports Encouraging Year-End Financials and Advances in DMD Therapy
Yahoo Finance
Financial Performance and Corporate Milestones. Capricor reported a substantial increase in revenue for the fourth quarter of 2023, reaching...
2 months ago
Earnings Beat: Capricor Therapeutics, Inc. (NASDAQ:CAPR) Just Beat Analyst Forecasts, And Analysts Have Been ...
Yahoo Finance
Following the recent earnings report, the consensus from four analysts covering Capricor Therapeutics is for revenues of US$21.4m in 2024. This...
1 month ago
Wall Street Analysts Predict a 218.18% Upside in Capricor (CAPR): Here's What You Should Know
Yahoo Finance
Shares of Capricor Therapeutics (CAPR) have gained 11.9% over the past four weeks to close the last trading session at $6.60,...
3 weeks ago